Disease Biology

2:40
Resistance to IMiDs in MM
Enrique Ocio
1:28
Enhancing immune response in multiple myeloma
Sagar Lonial
1:07
Optimizing MM treatment through understanding resistance
Michel Delforge
3:57
Diagnosing and treating solitary plasmacytoma
Paula Rodríguez-Otero
2:22
Immune escape: from MGUS to multiple myeloma
Paola Neri
3:37
Genomic patterns in smoldering myeloma enhance timing of treatment initiation
Nikhil Munshi
6:47
Immunoepigenetic platforms for PTCL treatment
Owen O’Connor
2:18
Agressive or transformed MCL: prognostic factors, outcomes & mutational profile
Preetesh Jain
3:59
The critical role of SIRT3 in lymphomagenesis
Ari Melnick
7:18
Precision epigenetic therapy for B-cell lymphoma
Ari Melnick
1:14
ALPS disease and ALPS phenotype: distinct entities?
Carlo Dufour
1:53
Telomere length screening
Carlo Dufour
1:39
SCD: Assessing bleeding severity in thrombocytopenic patients
Bart Biemond
3:36
New insights in Fanconi anemia
Carlo Dufour
3:29
Vaso-occlusion, multi-cell adhesion & the HOPE study
Bart Biemond
1:18
SCD: incentive spirometry
Bart Biemond
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals